THE WIRE · № 73448
Blood Cancer United Presents Inaugural Breakthrough Voice and Breakthrough Rising Leader Awards at First-Ever Night of Champions
01 THE MACHINE READ
WHY IT MATTERS.
Award ceremony for blood-cancer researchers highlights philanthropy and research attention but carries no direct investable signal.
Blood cancer nonprofit honors researchers at summit
Follow-on research funding or trial results
Ceremonial event with no financial disclosure
FULL DISPATCH
Dr. Siddhartha Mukherjee and Charlotte Nathanson honored during Blood Cancer United's Breakthroughs Summit in New York City NEW YORK, Oct. 9, 2026 /PRNewswire/ -- Blood Cancer United kicked off the reimagined Breakthroughs Summit last night with its first-ever Night of Champions,...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
Quince relaunches as IRulya, going all in on lung disease after Hail Mary merger2026-10-09 15:05 UTC
TRex prices IPO at bottom of range as Retension makes its public debut2026-10-09 17:48 UTC
TRex rakes in $117M IPO, while Retension reveals $45M listing2026-10-09 08:29 UTC
City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs2026-10-09 12:34 UTC
Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing2026-10-09 13:53 UTC
City Therapeutics targets $158M IPO; Iambic seeks $135M Nasdaq debut2026-10-09 14:15 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.